01
Mouth Swab Collection
A sterile cheek swab can collect epithelial cells containing DNA, creating a simple starting point for genomic testing workflows.
SeqSmart Diagnostics
AI-assisted genomic intelligence for preventative diagnostic science.
SeqSmart Diagnostics is a Rotger Research Foundation Inc. development-stage initiative designed to transform genomic information, AI evidence review, and medical research into structured reports for physician review.
SeqSmart is not being presented as a standalone medical diagnosis, treatment order, or replacement for licensed medical care. The program is being developed for research, physician-ready reporting, and responsible clinical-review pathways.
Program Purpose
Moving healthcare conversations earlier — before problems become emergencies.
The purpose of SeqSmart Diagnostics is to support a more preventative model of diagnostic science. The initiative is being developed to help organize complex genomic information, identify research-supported areas of concern, and prepare clearer information that can be reviewed with licensed medical professionals.
From Data to Insight
A scientific pipeline built around genomics, AI, and clinical review.
The long-term vision is to connect DNA sequencing, bioinformatics, AI research analysis, and doctor-ready reporting in one responsible workflow.
How the Workflow Works
From mouth swab to physician-ready genomic intelligence.
This page now explains the process in a way that donors, physicians, advisors, and partners can understand without overstating clinical claims.
02
DNA Extraction & Quality Control
The sample is processed to isolate DNA, confirm quality, and prepare the biological material for sequencing.
03
Genome Sequencing
Sequencing converts DNA into digital genomic information that can be organized, aligned, and reviewed through bioinformatics.
04
AI Supercomputer Analysis
SeqSmart is being designed to analyze variants, risk patterns, biological pathways, and research-supported disease associations.
05
Physician-Ready Report
The intended report helps doctors review findings, order confirmatory testing, and determine appropriate next steps.
Core Capabilities Under Development
Built as a research-grade intelligence layer, not a replacement for doctors.
The program is being positioned around responsible technical development, clinical collaboration, and evidence-based reporting.
01
Genomic Variant Intelligence
Reviewing genetic variants, inheritance patterns, possible disease associations, and findings that may require confirmatory medical evaluation.
02
Research Evidence Review
Searching scientific literature, treatment research, pharmacogenomic evidence, and clinical guidance to support physician interpretation.
03
Structured Clinical Reporting
Preparing organized, physician-ready reports with clear sections, evidence summaries, possible follow-ups, and responsible disclaimers.
Responsible Development
Scientific credibility comes from the structure behind the system.
SeqSmart should be built with the same seriousness expected of health technology: advisory oversight, data security, documentation, validation planning, and physician-review safeguards.
- Human-subjects protection planningResearch protocols, informed consent, and appropriate IRB review when human samples or health data are involved.
- CLIA/CAP laboratory partnership pathwaySequencing and clinical testing should be performed through qualified laboratory partners before any clinical use.
- HIPAA-informed data securityAccess controls, encryption, breach procedures, data retention rules, and privacy-first genomic data handling.
- Medical software development disciplineQuality management, risk controls, software validation, cybersecurity planning, and regulatory review before clinical deployment.
Important Medical Boundary
What the system should say — and what it should not say yet.
Correct positioning: “SeqSmart helps identify possible genomic findings, disease pathways, and treatment research for physician review.”
Avoid: “SeqSmart diagnoses disease and tells patients what treatment to take.”
This distinction protects the foundation, improves credibility with medical partners, and makes the page stronger for donors, advisors, and future grant applications.
Development Roadmap
Building the platform before launching the clinic.
The responsible path begins with research, software development, data security planning, advisory support, and lab partnerships before any patient-facing clinical deployment.
Questions & Answers
Clear answers for donors, partners, and future participants.
Is SeqSmart currently a clinical diagnostic product?
No. This page presents SeqSmart as a development-stage AI-assisted genomic intelligence initiative. It should not be marketed as a standalone clinical diagnostic service unless the required medical, laboratory, privacy, and regulatory pathways are completed.
Will the AI replace doctors?
No. The intended model is physician-ready reporting. The AI can organize genomic information, surface possible findings, and review evidence, but licensed medical professionals must interpret results in context.
How will privacy be handled?
The program should be developed with strict data protection, encryption, access controls, audit logs, consent procedures, and privacy-first genomic data handling.
How will donations be used?
Donations may support software development, secure infrastructure planning, scientific advisory support, research preparation, educational outreach, and long-term laboratory development goals.
Community Impact
Why this matters.
Preventative diagnostic science has the potential to help families and physicians ask better questions earlier. RRF’s role is to build the educational, scientific, and development foundation needed to responsibly explore that future.
- Earlier insightHelping move from late reaction toward earlier understanding and risk awareness.
- Better questions for doctorsSupporting more informed conversations between patients, families, and licensed healthcare providers.
- Research accessMaking advanced diagnostic science more visible, understandable, and community-centered.
SeqSmart Diagnostic Science Lab Development Fund
Help build the platform, advisory structure, and future laboratory vision.
Your donation supports the responsible development of SeqSmart Diagnostics through software planning, secure genomic data infrastructure, scientific advisory support, research preparation, educational outreach, and long-term lab development.
$100Supports research and educational development materials.
$500Helps fund technical workflow and infrastructure planning.
$1,000Contributes to advisory, research, and validation readiness.
$5,000+Supports major lab development and long-term platform goals.
Rotger Research Foundation Inc.
The future of diagnostic science must be intelligent, ethical, and physician-guided.
SeqSmart Diagnostics is being developed to help turn genomic data into clearer, research-supported insight for medical review — while keeping patient safety, privacy, and scientific responsibility at the center.